The identification of prognostic biomarkers and novel therapeutic targets in lung squamous cell carcinoma (SCC) is crucial. We analyzed the presence of the FGFR4-388Arg variant in 114 SCC patients and related it to increased MAPK signaling, and to reduced survival in lymph node-affected patients. These findings suggest that FGFR4 targeting in these patients may be a potential therapeutic strategy.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2q4gufo
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Background. Reconstruction of surgical defects following cranial base surgery is challenging. Others have demonstrated that leukocyte-platel...
-
During lytic infection, herpes simplex virus (HSV) DNA is replicated by a mechanism involving DNA recombination. For instance, replication o...
-
IJMS, Vol. 18, Pages 1603: Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indic...
-
Dracaena cochinchinensis Lour. is an ethnomedicinally important plant used in traditional Chinese medicine known as dragon’s blood. Excessiv...
-
Taking a slurry reservoir-pipeline-valve system as research object, axial dynamic vibrations of pipe system were induced by coupled hydrauli...
-
Women in Love by . Lawrence. Searchable etext. Discuss with other readers. from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Ino...
-
by Emily M. Zygiel, Karen A. Noren, Marta A. Adamkiewicz, Richard J. Aprile, Heather K. Bowditch, Christine L. Carroll, Maria Abigail S. Cer...
-
Publication date: February 2017 Source: Cryobiology, Volume 74 Author(s): Reza Masoudi, Ahmad Zare Shahneh, Armin Towhidi, Hamid Kohram, A...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου